BioStem Technologies, Inc.
BSEM
$14.69
$0.1621.12%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.62M | 5.27M | -2.69M | -10.71M | -11.70M |
| Total Depreciation and Amortization | 258.50K | 215.20K | 225.10K | 228.90K | 232.10K |
| Total Amortization of Deferred Charges | 377.30K | 275.10K | 249.20K | 217.20K | 50.90K |
| Total Other Non-Cash Items | 7.48M | 11.25M | 8.40M | 7.62M | 8.70M |
| Change in Net Operating Assets | -6.84M | -11.95M | -8.45M | -842.50K | 189.80K |
| Cash from Operations | 14.91M | 5.06M | -2.26M | -3.49M | -2.52M |
| Capital Expenditure | -295.20K | -268.70K | -57.80K | -105.30K | -149.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -105.00K | -105.00K | -105.00K | -105.00K | -225.90K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.15M | 105.00K | 105.30K | 0.00 | 94.60K |
| Cash from Investing | -1.55M | -268.70K | -57.60K | -210.30K | -280.70K |
| Total Debt Issued | 60.90K | 549.40K | 1.63M | 1.63M | 2.32M |
| Total Debt Repaid | -1.20M | -1.35M | -1.23M | -844.20K | -895.20K |
| Issuance of Common Stock | 2.29M | 2.26M | 2.42M | 2.38M | 444.50K |
| Repurchase of Common Stock | 0.00 | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.14M | 1.46M | 2.82M | 3.17M | 1.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | -- | 0.00 |
| Net Change in Cash | 14.50M | 6.25M | 494.50K | -532.80K | -931.60K |